RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,376,063 | -26.6% | 1,406,502 | -17.4% | 0.00% | -50.0% |
Q2 2023 | $31,828,242 | +5.8% | 1,702,045 | +3.8% | 0.00% | 0.0% |
Q1 2023 | $30,076,494 | -60.9% | 1,639,046 | -57.8% | 0.00% | 0.0% |
Q4 2022 | $76,852,630 | +150.7% | 3,881,446 | +204.7% | 0.00% | 0.0% |
Q3 2022 | $30,650,000 | +242.2% | 1,273,891 | +159.5% | 0.00% | +100.0% |
Q2 2022 | $8,958,000 | -69.8% | 490,865 | -63.6% | 0.00% | 0.0% |
Q1 2022 | $29,633,000 | -35.1% | 1,347,581 | +8.3% | 0.00% | -50.0% |
Q4 2021 | $45,684,000 | +326.7% | 1,243,787 | +260.7% | 0.00% | +100.0% |
Q3 2021 | $10,707,000 | +24.5% | 344,837 | +27.5% | 0.00% | – |
Q2 2021 | $8,598,000 | +99.5% | 270,456 | +39.3% | 0.00% | – |
Q1 2021 | $4,310,000 | +12.9% | 194,166 | +0.4% | 0.00% | – |
Q4 2020 | $3,819,000 | -36.4% | 193,372 | +3.8% | 0.00% | – |
Q3 2020 | $6,000,000 | +16.2% | 186,328 | +4.7% | 0.00% | – |
Q2 2020 | $5,164,000 | +906.6% | 177,949 | +637.4% | 0.00% | – |
Q1 2020 | $513,000 | +89.3% | 24,133 | +146.3% | 0.00% | – |
Q4 2019 | $271,000 | – | 9,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |